The Netherlands' number 1 in weight loss

Your

treatment plan

Dr. Diego Keijzer

Head of Medical Services

Based on your situation, we recommend the treatment plan below. Once our doctor approves it, you will receive the treatment discreetly at home within 2 business days.

Wegovy

Every 4 weeks
The best subscription for you

Wegovy, with the active ingredient semaglutide, activates GLP-1 receptors to suppress appetite and stimulate weight loss. Scientifically proven effective and supported by medical research, it sustainably aids in weight management.

Flexible subscription with free shipping (pause or cancel anytime)
Less hunger, feel full faster
Weekly injections (4 per delivery)
Clinically proven effective
Weight loss
10 - 20%
Active ingredient
Semaglutide
Dosage
0.25 mg - 2.4 mg
Price
€ 249
€ 149 / 4 weeks

If you start now,

in 10 months, you can achieve an average result of

- 20%

Based on the STEP-1 study, published in the New England Journal of Medicine in February 2021.

Why Wegovy is the best option for you.

Your BMI indicates that weight loss medication can safely and effectively help you reach your target weight and improve your energy and well-being.

How does weight loss medication help you?

Lasting weight loss (no yo-yo effect)
Finally, build a healthy lifestyle (one that suits you and you can maintain)
With ongoing support (you won't be alone)

Dr. Diego Keijzer

Chief Medical Officer

Chief Medical Officer
GP

Today, take the first step towards a healthier, lighter life.

Once approved by our doctor, your treatment will be delivered to your home within 2 business days.

The Netherlands' leading weight loss solution
Explore other treatments
Mounjaro
Tirzepatide GLP-1
Meest Effectief
359
323.1
Mounjaro, with the active ingredient tirzepatide, stimulates GLP-1 and GIP receptors to reduce appetite and promote weight loss. Scientifically proven effective and supported by medical research, it offers optimal weight control support.
Every
4 weken
More information
Ozempic
Semaglutide GLP-1
Populair
249
179
Ozempic, with semaglutide, activates GLP-1 receptors to suppress appetite and promote weight loss. Scientifically based and medically supervised, ideal for effective and sustainable weight control.
Every
4 weken
More information